Search hospitals > Tennessee > Franklin
Vanderbilt-Ingram Cancer Center Cool Springs
Claim this profileFranklin, Tennessee 37064
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Head and Neck Cancers
Conducts research for Stomach Cancer
129 reported clinical trials
11 medical researchers
Summary
Vanderbilt-Ingram Cancer Center Cool Springs is a medical facility located in Franklin, Tennessee. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Head and Neck Cancers, Stomach Cancer and other specialties. Vanderbilt-Ingram Cancer Center Cool Springs is involved with conducting 129 clinical trials across 282 conditions. There are 11 research doctors associated with this hospital, such as Elizabeth J. Davis, Jordan Berlin, MD, Vandana Abramson, M.D., and Ingrid A Mayer, MD.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
Elizabeth J. DavisVanderbilt University/Ingram Cancer Center5 years of reported clinical research
Studies Cancer
Studies Soft Tissue Sarcoma
18 reported clinical trials
24 drugs studied
Jordan Berlin, MDVanderbilt-Ingram Cancer Center8 years of reported clinical research
Studies Solid Tumors
Studies Colorectal Cancer
13 reported clinical trials
21 drugs studied
Vandana Abramson, M.D.Vanderbilt University/Ingram Cancer Center8 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
14 reported clinical trials
31 drugs studied
Ingrid A Mayer, MDVanderbilt University/Ingram Cancer Center3 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
10 reported clinical trials
30 drugs studied
Clinical Trials running at Vanderbilt-Ingram Cancer Center Cool Springs
Breast Cancer
Bladder Carcinoma
Bladder Cancer
Lung Cancer
Skin Cancer
Kidney Cancer
Breast cancer
Penile Cancer
Urethral Cancer
Kidney Carcinoma
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Vanderbilt-Ingram Cancer Center Cool Springs?
Vanderbilt-Ingram Cancer Center Cool Springs is a medical facility located in Franklin, Tennessee. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Head and Neck Cancers, Stomach Cancer and other specialties. Vanderbilt-Ingram Cancer Center Cool Springs is involved with conducting 129 clinical trials across 282 conditions. There are 11 research doctors associated with this hospital, such as Elizabeth J. Davis, Jordan Berlin, MD, Vandana Abramson, M.D., and Ingrid A Mayer, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.